ZANTAC USERS – READ THIS NOW!!

ZANTAC USERS – READ THIS NOW!!

One manufacturer of generic ranitidine (Zantac), Novartis’s Sandoz unit, has reportedly decided to halt distribution of the antacid drug until a contamination issue is resolved.

Last week, the FDA said some lots of ranitidine, a histamine H2 inhibitor, were found to contain small amounts of N-nitrosodimethylamine (NDMA), considered to be a human carcinogen. Read in greater detail the attached links:

https://www.nytimes.com/2019/09/19/health/zantac-recall.html

https://www.medpagetoday.com/gastroenterology/gerd/82238